PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Apr-2020 Quell Therapeutics Enters a Collaborative Research Agreement with the Hannover Medical School Quell Therapeutics
08-Apr-2020 Réf. DC 058(2020) COVID-19: How to protect yourself from falsified medical products? MEDICRIME Committee
08-Apr-2020 Lamellar Biomedical launches program designed to prevent the severe respiratory effects of COVID-19, using its unique LAMELLASOME™ Technology Lamellar Biomedical
08-Apr-2020 The Life Sciences Sector Post-Brexit (So Far) UK life sciences
08-Apr-2020 Leading Korean pharmaceutical manufacturer transforms drug processing with Quantum 600 pump Sciad Newswire
08-Apr-2020 Harrington Discovery Institute Issues Transatlantic Call for Proposals to Treat Coronavirus and its Clinical Impact Harrington Discovery Institute
08-Apr-2020 Asklepios Kliniken: COMMENCEMENT OF ACCEPTANCE PERIOD FOR PUBLIC TAKEOVER OFFER SUBMITTED BY ASKLEPIOS KLINIKEN GMBH & CO. KGAA FOR THE SHARES OF RHÖN-KLINIKUM AG Asklepios Kliniken
08-Apr-2020 MetrioPharm AG: MetrioPharm Successfully Completes Study in COPD Model MetrioPharm AG
08-Apr-2020 Medios AG with record year 2019 - Optimistic outlook for 2020 despite corona pandemic Medios AG
08-Apr-2020 4SC AG: FDA Accepts IND Application for MERKLIN 2 Study 4SC AG
08-Apr-2020 Dermapharm confirms profitable growth in 2019 and presents positive outlook for 2020 despite corona Dermapharm Holding SE
08-Apr-2020 Rapid Nutrition Announces New Distribution Partnership with Brazilian BFG Brasil Comercio de Vitaminas LTDA Rapid Nutrition PLC
07-Apr-2020 Willow Biosciences Announces Changes to its Management Team Willow Biosciences Inc.
07-Apr-2020 PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA) PTC Therapeutics, Inc.
07-Apr-2020 Alleviating Confusion around Pain Management Recommendations National Comprehensive Cancer Network
07-Apr-2020 COGNITANT GROUP TO LAUNCH HEALTHNIOTE APP WITH VERIFIED NHS CORONAVIRUS GUIDANCE Cognitant Group
07-Apr-2020 First-in-class cholesterol-lowering treatment NILEMDO®▼ (bempedoic acid) and NUSTENDI®▼ (bempedoic acid / Ezetimibe) approved in Europe Daiichi Sankyo Europe GmbH
07-Apr-2020 Eli Lilly and Company to Hold 2020 Annual Meeting of Shareholders Virtually Eli Lilly and Company
07-Apr-2020 FDA Accelerates Development of Novel Therapies for COVID-19 Financialnewsmedia.com
07-Apr-2020 Q BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt Conversion Q BioMed Inc.